Merck's Bravecto Quantum long-acting flea and tick treatment for dogs approved by FDA.

Merck Animal Health's long-acting flea and tick treatment, Bravecto Quantum, has earned FDA approval for dogs over six months old. The injectable treatment protects against fleas and ticks for 8-12 months and can be used for treating and preventing flea infestations and tick infestations. The FDA warns that the treatment can cause neurological adverse reactions in some dogs. Veterinary clinics will start offering Bravecto Quantum next month.

The U.S. Food and Drug Administration (FDA) has approved Merck Animal Health's Bravecto Quantum (fluralaner for extended-release injectable suspension) for dogs over six months old. This injectable treatment offers 8-12 months of protection against fleas and ticks, making it a significant advancement in veterinary care.

Bravecto Quantum is the first FDA-approved drug to provide such long-lasting protection against fleas and ticks. It is indicated for treating and preventing flea infestations and tick infestations for 12 months in dogs and puppies 6 months of age and older. The product also offers 8 months of protection against Amblyomma americanum (lone star ticks) infestations [1].

The approval of Bravecto Quantum follows its successful introduction in Australia and New Zealand in 2023, and the European Union in 2024. It is now available in more than 50 countries worldwide. Merck Animal Health, a division of Merck & Co., Inc., is excited to offer this convenient, year-long protection against fleas and ticks in a single injection [2].

The FDA has warned that Bravecto Quantum can cause neurological adverse reactions, including muscle tremors, ataxia, and seizures, in some dogs. Therefore, it should only be prescribed by a licensed veterinarian who can properly administer the injection and monitor for adverse reactions [1].

The product is expected to be available at veterinary clinics and hospitals nationwide by August 2025. Merck Animal Health emphasizes that Bravecto Quantum sets a new standard in pet care by providing a safe and effective option for flea and tick protection for dogs.

References:
[1] https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-first-long-acting-flea-and-tick-treatment-dogs
[2] https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-FDA-approval-for-Bravecto-Quantum-50488339/